Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuewen Liu

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
Archives of Biochemistry and Biophysics|February 24, 2020
Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activityJiaxin Xu, Yunhe Chen, Rui Yang, et al.
Biochemical Pharmacology|October 5, 2025
GA-017 attenuates OA by activating YAP/TAZXinhuo Li, Mingyang Lei, Qiannan Ding, et al.
Cancer Science|October 5, 2021
G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptorYuan Si, Haitao Zhang, Peng Peng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 16, 2023
Sculponeatin A promotes the ETS1-SYVN1 interaction to induce SLC7A11/xCT-dependent ferroptosis in breast cancerPeng Peng, Yuliang Ren, Fang Wan, et al.
Translational Oncology|January 13, 2017
Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK InhibitorXinru Chen, Yu Zhang, Jiabin Lu, et al.
Archives of Biochemistry and Biophysics|March 30, 2025
Corrigendum to "Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity" [Archiv. Biochem. Biophys. 684 (2020) 108314]Jiaixin Xu, Yunhe Chen, Rui Yang, et al.
Oncotarget|November 19, 2016
Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapyTingting Feng, Wei Cao, Wanxiang Shen, et al.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2025
Neoadjuvant immunotherapy plus chemotherapy in locally advanced stage III NSCLC patients undergoing definitive chemo-radiotherapy---a real‑world multicenter retrospective studyGuoyin Li, Chaoyuan Liu, Pan Xi, et al.
Biomaterials Science|January 21, 2025
A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cellsJiahao Liu, Long Wang, Yongbo Peng, et al.
Cell Death & Disease|March 29, 2025
CSF3R-AS promotes hepatocellular carcinoma progression and sorafenib resistance through the CSF3R/JAK2/STAT3 positive feedback loopZiyang Feng, Yan Gao, Changjing Cai, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Archives of Biochemistry and Biophysics|February 24, 2020
Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activityJiaxin Xu, Yunhe Chen, Rui Yang, et al.
Biochemical Pharmacology|October 5, 2025
GA-017 attenuates OA by activating YAP/TAZXinhuo Li, Mingyang Lei, Qiannan Ding, et al.
Cancer Science|October 5, 2021
G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptorYuan Si, Haitao Zhang, Peng Peng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 16, 2023
Sculponeatin A promotes the ETS1-SYVN1 interaction to induce SLC7A11/xCT-dependent ferroptosis in breast cancerPeng Peng, Yuliang Ren, Fang Wan, et al.
Translational Oncology|January 13, 2017
Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK InhibitorXinru Chen, Yu Zhang, Jiabin Lu, et al.
Archives of Biochemistry and Biophysics|March 30, 2025
Corrigendum to "Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity" [Archiv. Biochem. Biophys. 684 (2020) 108314]Jiaixin Xu, Yunhe Chen, Rui Yang, et al.
Oncotarget|November 19, 2016
Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapyTingting Feng, Wei Cao, Wanxiang Shen, et al.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2025
Neoadjuvant immunotherapy plus chemotherapy in locally advanced stage III NSCLC patients undergoing definitive chemo-radiotherapy---a real‑world multicenter retrospective studyGuoyin Li, Chaoyuan Liu, Pan Xi, et al.
Biomaterials Science|January 21, 2025
A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cellsJiahao Liu, Long Wang, Yongbo Peng, et al.
Cell Death & Disease|March 29, 2025
CSF3R-AS promotes hepatocellular carcinoma progression and sorafenib resistance through the CSF3R/JAK2/STAT3 positive feedback loopZiyang Feng, Yan Gao, Changjing Cai, et al.
Pageof 15